|
1
|
Lu X, Hongcai S, Jiaying W, Jing H and Jun
X: Assessing the quality of reports about randomized controlled
trials of acupuncture treatment on mild cognitive impairment. PLoS
One. 6:e169222011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leung MC, Yip KK, Ho YS, Siu FK, Li WC and
Garner B: Mechanisms underlying the effect of acupuncture on
cognitive improvement: A systematic review of animal studies. J
Neuroimmune Pharmacol. 9:492–507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aggarwal NT, Tripathi M, Dodge HH, Alladi
S and Anstey KJ: Trends in Alzheimer’s disease and dementia in the
Asian-pacific region. Int J Alzheimers Dis. 2012.171327:2012.
|
|
4
|
World Health Organization and Alzheimer’s
Disease International Dementia: A public health priority. World
Health Organization; Geneva: 2012
|
|
5
|
Rabinstein AA and Shulman LM: Acupuncture
in clinical neurology. Neurologist. 9:137–148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu J, Zhang X, Liu C, Meng Y and Han J:
Effect of acupuncture treatment on vascular dementia. Neurol Res.
28:97–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chou P, Chu H and Lin JG: Effects of
electroacupuncture treatment on impaired cognition and quality of
life in Taiwanese stroke patients. J Altern Complement Med.
15:1067–1073. 2009.
|
|
8
|
Shen PF, Kong L, Ni LW, Guo HL, Yang S,
Zhang LL, Zhang ZL, Guo JK, Xiong J, Zhen Z and Shi XM: Acupuncture
intervention in ischemic stroke: A randomized controlled
prospective study. Am J Chin Med. 40:685–693. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi GX, Liu CZ, Li QQ, Zhu H and Wang LP:
Influence of acupuncture on cognitive function and markers of
oxidative DNA damage in patients with vascular dementia. J
Traditional Chin Med. 32:199–202. 2012. View Article : Google Scholar
|
|
10
|
Wang J, Markesbery WR and Lovell MA:
Increased oxidative damage in nuclear and mitochondrial DNA in mild
cognitive impairment. J Neurochem. 96:825–832. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Manczak M, Anekonda TS, Henson E, Park BS,
Quinn J and Reddy PH: Mitochondria are a direct site of Aβ
accumulation in Alzheimer’s disease neurons: Implications for free
radical generation and oxidative damage in disease progression. Hum
Mol Genetics. 15:1437–1449. 2006. View Article : Google Scholar
|
|
12
|
Pappolla MA, Omar RA, Kim KS and Robakis
NK: Immunohistochemical evidence of oxidative [corrected] stress in
Alzheimer’s disease. Am J Pathol. 140:621–628. 1992.PubMed/NCBI
|
|
13
|
Bozner P, Grishko V, LeDoux SP, Wilson GL,
Chyan YC and Pappolla MA: The amyloid beta protein induces
oxidative damage of mitochondrial DNA. J Neuropathol Exp Neurol.
56:1356–1362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pappolla MA, Chyan YJ, Omar RA, Hsiao K,
Perry G, Smith MA and Bozner P: Evidence of oxidative stress and in
vivo neurotoxicity of beta-amyloid in a transgenic mouse model of
Alzheimer’s disease: A chronic oxidative paradigm for testing
antioxidant therapies in vivo. Am J Pathol. 152:871–877.
1998.PubMed/NCBI
|
|
15
|
Yu CE, Seltman H, Peskind ER, Galloway N,
Zhou PX, Rosenthal E, Wijsman EM, Tsuang DW, Devlin B and
Schellenberg GD: Comprehensive analysis of APOE and selected
proximate markers for late-onset Alzheimer’s disease: Patterns of
linkage disequilibrium and disease/marker association. Genomics.
89:655–665. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Caselli RJ, Dueck AC, Huentelman MJ, Lutz
MW, Saunders AM, Reiman EM and Roses AD: Longitudinal modeling of
cognitive aging and the TOMM40 effect. Alzheimers Dement.
8:490–495. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roses AD, Lutz MW, Crenshaw DG, Grossman
I, Saunders AM and Gottschalk WK: TOMM40 and APOE: Requirements for
replication studies of association with age of disease onset and
enrichment of a clinical trial. Alzheimers Dement. 9:132–136. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ferencz B, Karlsson S and Kalpouzos G:
Promising genetic biomarkers of preclinical Alzheimer’s disease:
The influence of APOE and TOMM40 on brain integrity. Int J
Alzheimers Dis. 2012.421452:2012.
|
|
19
|
Zhang X, Wu B, Nie K, Jia Y and Yu J:
Effects of acupuncture on declined cerebral blood flow, impaired
mitochondrial respiratory function and oxidative stress in
multi-infarct dementia rats. Neurochem Int. 65:23–29. 2014.
View Article : Google Scholar
|
|
20
|
Peng J, Zeng F, He YH, Tang Y, Yin HY and
Yu SG: Observation on the protective effect of electroacupuncture
on hippocampal neuronal mitochondria in SAMP 8 mice. Acupuncture
Res. 32:3642007.In Chinese.
|
|
21
|
Li RQ, Wan MY, Shi J, Wang HL, Liu FL, Liu
CM, Huang J, Liu RC, Ma L and Feng XD: Catgut implantation at
acupoints increases the expression of glutamate aspartate
transporter and glial glutamate transporter-1 in the brain of rats
with spasticity after stroke. Neural Regen Res. 13:1013–1018. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hua XB: The development of the rat
acupuncture point. Exper Anim Anim Exper. 1:1–6. 1991.
|
|
23
|
Chu Q, Yu J and Han J: Improvement of
acupuncture on cognitive function in senescence accelerated mouse
P8. Chin J Behav Med Sci. 14:964–965. 2005.
|
|
24
|
Liu CZ, Yu JC, Cheng HY, Jiang ZG, Li T,
Zhang XZ, Zhang LL and Han JX: Spatial memory performance and
hippocampal neuron number in osteoporotic SAMP6 mice. Exp Neurol.
201:452–460. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Kim SA, Lee BH, Bae JH, Kim KJ, Steffensen
SC, Ryu YH, Leem JW, Yang CH and Kim HY: Peripheral afferent
mechanisms underlying acupuncture inhibition of cocaine behavioral
effects in rats. PLoS One. 8:e810182013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Patil S, Sen S, Bral M, Reddy S, Bradley
KK, Cornett EM, Fox CJ and Kaye AD: The role of acupuncture in pain
management. Curr Pain Headache Rep. 20:222016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnston MF, Yang C, Hui KK, Xiao B, Li XS
and Rusiewicz A: Acupuncture for chemotherapy-associated cognitive
dysfunction: A hypothesis-generating literature review to inform
clinical advice. Integr Cancer Ther. 6:36–41. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu J, Liu C, Zhang X and Han J:
Acupuncture improved cognitive impairment caused by multi-infarct
dementia in rats. Physiol Behav. 86:434–441. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu CZ, Yu JC, Zhang XZ, Fu WW, Wang T and
Han JX: Acupuncture prevents cognitive deficits and oxidative
stress in cerebral multi-infarction rats. Neurosci Lett. 393:45–50.
2006. View Article : Google Scholar
|
|
31
|
Madsen MV, Gøtzsche PC and Hróbjartsson A:
Acupuncture treatment for pain: Systematic review of randomised
clinical trials with acupuncture, placebo acupuncture, and no
acupuncture groups. BMJ. 338:a31152009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zeng F and Yu SG: The mechanism involved
in the treatment of senile dementia via regulation fo Du Channel. J
Sichuan Tradit Chin Med. 22:19–21. 2004.In Chinese.
|
|
33
|
Cantuti-Castelvetri I, Shukitt-Hale B and
Joseph JA: Neurobehavioral aspects of antioxidants in aging. Int J
Dev Neurosci. 18:367–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ryglewicz D, Rodo M, Kunicki PK,
Bednarska-Makaruk M, Graban A, Lojkowska W and Wehr H: Plasma
antioxidant activity and vascular dementia. J Neurol Sci.
203:195–197. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wallace DC: Mitochondrial genetics: A
paradigm for aging and degenerative diseases. Science. 256:628–632.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wallace DC: Mitochondrial diseases in man
and mouse. Science. 283:1482–1488. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Reddy PH and Beal MF: Amyloid beta,
mitochondrial dysfunction and synaptic damage: Implications for
cognitive decline in aging and Alzheimer’s disease. Trends Mol Med.
14:45–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sultana R and Butterfield DA: Oxidatively
modified, mitochondria-relevant brain proteins in subjects with
Alzheimer disease and mild cognitive impairment. J Bioenerg
Biomembr. 41:441–446. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu G, Liang R and Xie JQ: Characteristics
of afferent fiber innervation on acupoint Zusanli (Chin). Sci Sin.
22:495–503. 1979.
|
|
40
|
Glenner GG and Wong CW: Alzheimer’s
disease: Initial report of the purification and characterization of
a novel cerebrovascular amyloid protein. Biochem Biophys Res
Commun. 120:885–890. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tabner BJ, Turnbull S, El-Agnaf OM and
Allsop D: Formation of hydrogen peroxide and hydroxyl radicals from
A(beta) and alpha-synuclein as a possible mechanism of cell death
in Alzheimer’s disease and Parkinson’s disease 1, 2. Free Radic
Biol Med. 32:1076–1083. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
McBride HM, Neuspiel M and Wasiak S:
Mitochondria: More than just a powerhouse. Curr Biol. 16:R551–R560.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Humphries AD, Streimann IC, Stojanovski D,
Johnston AJ, Yano M, Hoogenraad NJ and Ryan MT: Dissection of the
mitochondrial import and assembly pathway for human Tom40. J Biol
Chem. 280:11535–11543. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Strittmatter WJ, Weisgraber KH, Huang DY,
Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM,
Goldgaber D and Roses AD: Binding of human apolipoprotein E to
synthetic amyloid beta peptide: Isoform-specific effects and
implications for late-onset Alzheimer disease. Proc Natl Acad Sci
USA. 90:8098–8102. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sanan DA, Weisgraber KH, Russell SJ,
Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T,
Frangione B and Roses AD: Apolipoprotein E associates with beta
amyloid peptide of Alzheimer’s disease to form novel monofibrils.
Isoform apoE4 associates more efficiently than apoE3. J Clin
Invest. 94:860–869. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ye S, Huang Y, Müllendorff K, Dong L,
Giedt G, Meng EC, Cohen FE, Kuntz ID, Weisgraber KH and Mahley RW:
Apolipoprotein (apo) E4 enhances amyloid β peptide production in
cultured neuronal cells: ApoE structure as a potential therapeutic
target. Proc Natl Acad Sci USA. 102:18700–18705. 2005. View Article : Google Scholar
|
|
47
|
Salhab M, Patani N, Jiang W and Mokbel K:
High TIMM17A expression is associated with adverse pathological and
clinical outcomes in human breast cancer. Breast Cancer.
19:153–160. 2012. View Article : Google Scholar
|
